Summary:
GI Associates is currently enrolling a research study, assessing the safety and effectiveness of an investigational dose of an already approved, oral medication in Crohn’s disease.
Qualified Participants Must:
• Be 18 years of age or older
•
Have active, moderate Crohn’s disease
•
Be willing to attend up to 17 office visits over 57 weeks
•
Other conditions may apply
Qualified Participants May Receive:
Study-related drug at no cost, Study-related medical exams at no cost and you may be compensated for time and travel